More from Mark Russinovich’s Ignite 2025 sessions, detailing software developments that underpin Microsoft’s move to ...
Five months after giving up on its lead drug Betalutin for follicular lymphoma, Nordic Nanovector has charted a course forward via a merger with fellow Norwegian biotech APIM Therapeutics. The merger ...
ZDNET experts put every product through rigorous testing and research to curate the best options for you. If you buy through our links, we may earn a commission. Learn Our Process 'ZDNET Recommends': ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback